We think Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (including cannabis derived chemicals) for neuropathic pain is worthy of a close look. Cannabis regulation has been relaxing both globally and in the United States and this influences our stance on CARA stock....
Barry Honig is one of the biotech space's most renowned entrepreneurs and investors. Along with his compatriot, Dr. Phillip Frost, he has been responsible for some of the big name successes in the sector. Many investors like to piggyback his positions, so here's one he just announced. In a just...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Intellia Therapeutics Inc. (NASDAQ:NTLA) reported that Caribou Biosciences, Inc. has picked up 5,593,846 of common stock as of 2017-02-28. The acquisition brings the aggregate amount owned by Caribou Biosciences, Inc. to a total of 5,593,846 ...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Fluidigm Corp (NASDAQ:FLDM) reported that Adage Capital Management has picked up 1,546,209 of common stock as of 2017-03-13. The acquisition brings the aggregate amount owned by Adage Capital Management to a total of 1,546,209 representing...
Some of the biggest biotechnology winners of 2017 so far are cannabis stocks. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a $3 billion pharmaceutical cannabis company and probably the most well known company in this subsector of healthcare, is up around 7% since the start of the year. Zynerba Pharmaceuticals Inc...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01. The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cas Medical Systems Inc. (NASDAQ:CASM) reported that Patton Thomas M has picked up 1,623,389 of common stock as of 2017-04-04. The acquisition brings the aggregate amount owned by Patton Thomas M to a total of...
Delcath Systems Inc (NASDAQ:DCTH) shares rose 7.59% on Tuesday to $0.170 and an additional 11.76% in after-hours trading to $0.190. The company has a market cap of $338K at 2.20 million shares outstanding. Delcath Systems Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Alliqua Biomedical Inc. (NASDAQ:ALQA) reported that Celgene Corp /de/ has picked up 8,025,194 of common stock as of 2017-03-16. The acquisition brings the aggregate amount owned by Celgene Corp /de/ to a total of 8,025,194...
Progressive Care Inc (OTCMKTS:RXMD) shares were up 24.41% on Monday to $0.0370 and flat in after-hours trading. Share prices have been trading in a 52-week range of $0.01 to $0.05. The company has a market cap of $11.92 million at 341.11 million shares outstanding. Progressive Care Inc is a health services...